Reference is made to the stock exchange announcement made by
Karo Pharma AB ("Karo Pharma") on 6 October 2017 regarding
completion of the voluntary offer (the "Voluntary Offer")
for the shares in Weifa ASA ("Weifa").
Karo Pharma currently owns 35,553,352 shares in Weifa
representing 97.48 % of Weifa's share capital and voting
The board of directors of Karo Pharma has pursuant to
Section 4-25 of the Norwegian Public Limited
Companies Act and Section 6-22 of the Norwegian Securities
Trading Act (the "STA") resolved to carry out a compulsory
acquisition of all the remaining shares in Weifa not already
owned by Karo Pharma (the "Minority Shares") effective from
end of trading on Oslo Stock Exchange today.
In accordance with section 6-22 (2) of the STA, the offered
redemption price for each Minority Share is NOK 35, which is
equal to the offer price in the Voluntary Offer.
As of today's date the rights and ownership of the Minority
Shares will automatically be transferred to
Karo Pharma, and accordingly Karo Pharma will from the day
hereof be the beneficial owner of 100 per cent of the Weifa
Karo Pharma has obtained a guarantee for the settlement
under the compulsory acquisition in accordance with section
6-22 (3) no. 3 of the STA.
Any objections to, or rejection of, the offered redemption
price must be made at the latest 15 December 2017. Former
shareholders of Weifa who do not object to, or reject, the
offered redemption price within this deadline will be deemed
to have accepted the offered price. Settlement of the offer
price to the minority shareholders will take place within 19
A letter regarding the compulsory acquisition will be sent
to all former shareholders of Weifa whose addresses are
known and whose shares have been acquired by way of the
compulsory acquisition. In addition, the compulsory
acquisition will be announced in the Brønnøysund Register
Center's electronic publication.
As a result of the compulsory acquisition, Karo Pharma will
pursue a delisting of the shares in Weifa from Oslo Stock
Exchange. A separate stock exchange announcement will be
published regarding such delisting.